These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4105672)

  • 1. Levodopa.
    Lancet; 1971 Sep; 2(7723):533. PubMed ID: 4105672
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
    N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of vitamin B 6 on levodopa-induced changes in spinal fluid homovanillic acid.
    Klawans HL
    J Neurol Sci; 1971 Dec; 14(4):421-6. PubMed ID: 5125757
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of response to levodopa in Parkinson's disease.
    Mones RJ
    JAMA; 1971 Aug; 217(9):1245. PubMed ID: 5109470
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pyridoxine on levodopa metabolism in normal and parkinsonian subjects.
    Hsu TH; Bianchine JR; Preziosi TJ; Messiha FS
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):578-81. PubMed ID: 4709027
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyridoxine antagonism of levodopa in parkinsonism.
    Leon AS; Spiegel HE; Thomas G; Abrams WB
    JAMA; 1971 Dec; 218(13):1924-7. PubMed ID: 5171069
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of Parkinson's disease].
    Castaigne P; Rondot P; Ribadeau-Dumas JL
    Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyridoxine reversal of L-dopa effects in Parkinsonism.
    Duvoisin RC; Yahr MD; Coté LD
    Trans Am Neurol Assoc; 1969; 94():81-4. PubMed ID: 5374494
    [No Abstract]   [Full Text] [Related]  

  • 11. L-Dopa and pyridoxine.
    Tran N
    Lancet; 1972 Jul; 2(7766):45-6. PubMed ID: 4113642
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of Parkinson's disease with levodopa.
    Campbell JB
    Neurology; 1970 Dec; 20(12):18-22. PubMed ID: 5531291
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption and metabolism of levodopa.
    Abrams WB; Coutinho CB; Leon AS; Spiegel HE
    JAMA; 1971 Dec; 218(13):1912-4. PubMed ID: 5171067
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 15. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J; Sharpe D; Curzon G
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral L-dopa treatment of parkinsonism.
    Andén NE; Carlsson A; Kerstell J; Magnusson T; Olsson R; Roos BE; Steen B; Steg G; Svanborg A; Thieme G; Werdinius B
    Acta Med Scand; 1970 Apr; 187(4):247-55. PubMed ID: 4911257
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa: alterations in behavior.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):383-96. PubMed ID: 4930867
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa and pyridoxine-deficient states.
    Friedman SA
    JAMA; 1970 Nov; 214(8):1563. PubMed ID: 5536356
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic modification of some neurologic disorders.
    Cotzias GC
    JAMA; 1969 Nov; 210(7):1255-62. PubMed ID: 5394649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.